Biotech

All Articles

Ionis axes eye condition from aim ats of Roche-partnered prospect after records dissatisfy

.Another of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of requiremen...

Biogen's chief executive officer said no risky sell 2023. He prepares to be daring

.While Biogen's pharma peers are actually looking for late-stage assets along with little bit of dan...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech trying to find a pipeline after it junked its...

Biogen bows out Denali Alzheimer's collab

.Biogen has returned civil rights to a very early Alzheimer's health condition plan to Denali Rehabs...

Takeda touches new mind people oncology company-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...

Vertex, hammered by AATD again, falls 2 possessions on discard heap

.Vertex's attempt to alleviate a rare genetic illness has struck an additional setback. The biotech ...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of team

.Vir Medical's second-quarter profits file wasn't except significant updates. The business invited a...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism case

.Galapagos has actually stopped briefly registration in a trial of a BCMA-directed CAR-T cell therap...

James Wilson leaving behind Penn to launch pair of new biotechs

.After much more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is actually l...

3 biotechs try to beat the summer season heat energy by losing personnel

.As biotechs try to switch a fresh webpage in August, at least three providers have actually lost pe...